FDA Will Consider Regeneron’s Covid-19 Antibody for Full Approval

FDA Will Consider Regeneron’s Covid-19 Antibody for Full Approval
·2 min read

The monoclonal antibody therapy, which is marketed under the name REGEN-COV, is currently available under an emergency-use authorization.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting